We are a European-based biomedical service provider that delivered contracted services to iSpecimen Inc. between 2023 and 2025. These services included biospecimen procurement, logistics, and support aligned with iSpecimen’s project timelines and internal coordination.
Despite successful delivery and operational confirmation on their side, a significant portion of the payment remains outstanding to this day, with no clear settlement timeline or satisfactory response from the company.
We are currently reviewing legal and regulatory pathways for formal resolution, including outreach to relevant U.S. oversight bodies and legal counsel.
If any other vendors, partners, or service providers have experienced similar difficulties with delayed or non-payment by iSpecimen Inc., we encourage you to reach out for confidential coordination.
This message is shared solely for the purpose of transparency and factual documentation of unresolved obligations.
We reserve all rights under applicable commercial and contract law. info@ukrainebiobank,com
Market Data 
Markets 
AI
